Skip to main content
. 2016 Sep 9;12:1744806916652409. doi: 10.1177/1744806916652409

Figure 2.

Figure 2.

Assessments of bone cancer-induced pain behavior. (a) Systemic administration of NB001 (30 mg/kg, ip, twice per day for three days) attenuated sarcoma-induced spontaneous lifting compared to saline treated model mice. (b) NB001 treatment improved limb-use on rotarod compared to saline treated model mice. (c) NB001 treatment reversed the mechanical hypersensitivity compared to saline treated model mice. Data are presented as mean ± SE, *p < 0.05 versus model.